Literature DB >> 18061561

Drosophila ASPP regulates C-terminal Src kinase activity.

Paul F Langton1, Julien Colombani, Birgit L Aerne, Nicolas Tapon.   

Abstract

Src-family kinases (SFKs) control a variety of biological processes, from cell proliferation and differentiation to cytoskeletal rearrangements. Abnormal activation of SFKs has been implicated in a wide variety of cancers and is associated with metastatic behavior (Yeatman, 2004). SFKs are maintained in an inactive state by inhibitory phosphorylation of their C-terminal region by C-terminal Src kinase (Csk). We have identified Drosophila Ankyrin-repeat, SH3-domain, and Proline-rich-region containing Protein (dASPP) as a regulator of Drosophila Csk (dCsk) activity. dASPP is the homolog of the mammalian ASPP proteins, which are known to bind to and stimulate the proapoptotic function of p53. We show that dASPP is a positive regulator of dCsk. First, dASPP loss-of-function strongly enhances the specific phenotypes of dCsk mutants in wing epithelial cells. Second, dASPP interacts physically with dCsk to potentiate the inhibitory phosphorylation of Drosophila Src (dSrc). Our results suggest a role for dASPP in maintaining epithelial integrity through dCsk regulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18061561     DOI: 10.1016/j.devcel.2007.11.005

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  21 in total

1.  When flies and mice develop cancer. Meeting on development and cancer.

Authors:  Offer Gerlitz; Erwin F Wagner; Eduardo Moreno
Journal:  EMBO Rep       Date:  2008-07-18       Impact factor: 8.807

Review 2.  Developmental and pathological lymphangiogenesis: from models to human disease.

Authors:  Hélène Maby-El Hajjami; Tatiana V Petrova
Journal:  Histochem Cell Biol       Date:  2008-10-23       Impact factor: 4.304

Review 3.  Echoes of a distant past: The cag pathogenicity island of Helicobacter pylori.

Authors:  Nicola Pacchiani; Stefano Censini; Ludovico Buti; Antonello Covacci
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

4.  Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP.

Authors:  Arnaud M Vigneron; Robert L Ludwig; Karen H Vousden
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

5.  Helicobacter pylori cytotoxin-associated gene A (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host.

Authors:  Ludovico Buti; Eric Spooner; Annemarthe G Van der Veen; Rino Rappuoli; Antonello Covacci; Hidde L Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-11       Impact factor: 11.205

6.  ASPP2 suppresses stem cell-like characteristics and chemoresistance by inhibiting the Src/FAK/Snail axis in hepatocellular carcinoma.

Authors:  Lu Xu; Xin Tong; Sujie Zhang; Fan Yin; Xiaoyan Li; Huafeng Wei; Cheng Li; Yajun Guo; Jian Zhao
Journal:  Tumour Biol       Date:  2016-07-29

7.  The snail repressor inhibits release, not elongation, of paused Pol II in the Drosophila embryo.

Authors:  Jacques P Bothma; Joe Magliocco; Michael Levine
Journal:  Curr Biol       Date:  2011-09-14       Impact factor: 10.834

Review 8.  Adherens Junction and E-Cadherin complex regulation by epithelial polarity.

Authors:  Peter Coopman; Alexandre Djiane
Journal:  Cell Mol Life Sci       Date:  2016-05-05       Impact factor: 9.261

9.  Autophagic activity dictates the cellular response to oncogenic RAS.

Authors:  Yihua Wang; Xiao Dan Wang; Eleonora Lapi; Alexandra Sullivan; Wei Jia; You-Wen He; Indrika Ratnayaka; Shan Zhong; Robert D Goldin; Christoph G Goemans; Aviva M Tolkovsky; Xin Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-30       Impact factor: 11.205

10.  BCAS2 is essential for Drosophila viability and functions in pre-mRNA splicing.

Authors:  Po-Han Chen; Chia-I Lee; Yu-Tzu Weng; Woan-Yuh Tarn; Yeou-Ping Tsao; Ping-Chang Kuo; Pang-Hung Hsu; Chu-Wei Huang; Chiun-Sheng Huang; Hsiu-Hsiang Lee; June-Tai Wu; Show-Li Chen
Journal:  RNA       Date:  2012-12-17       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.